Welcome to CDC stacks | Carriage of Neisseria meningitidis Serogroup W135 ST-2881 - 16160 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Carriage of Neisseria meningitidis Serogroup W135 ST-2881
  • Published Date:
    Sep 2006
  • Source:
    Emerg Infect Dis. 12(9):1421-1423.
Filetype[PDF-57.15 KB]


Details:
No Related Documents.
You May Also Like:
  1. Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
    Personal Author:
    Mueller, Judith E.; Sangaré, Lassana; Njanpop-Lafourcade, Berthe-Marie; Tarnagda, Zekiba; Traoré, Yves; Yaro, Seydou; Borrow, Raymond; Gessner, Bradford D.; Nicolas, Pierre;
    Published:
    Jun 2007
    Source:
    Emerg Infect Dis. 13(6):847-854.
    Description:
    To describe Neisseria meningitidis strains in the African meningitis belt in 2003, we obtained 2,389 oropharyngeal swabs at 5 monthly visits a representative population sample (age range 4-29 years) in Bobo-Dioulasso, Burkina Faso. A total of 152 car...
    File Type:
    Filetype[PDF - 323.79 KB]
  2. Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine
    Personal Author:
    Caugant, Dominique A.; Kristiansen, Paul A.; Wang, Xin; Mayer, Leonard W.; Taha, Muhamed-Kheir; Ouédraogo, Rasmata; Kandolo, Denis; Bougoudogo, Flabou; Sow, Samba; Bonte, Laurence;
    Published:
    Sep 27 2012
    Source:
    PLoS One. 7(9).
    Description:
    Background : The serogroup A conjugate meningococcal vaccine, MenAfriVac, was introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and Niger. In the coming years, vaccination will be extended to other African countries at r...
    File Type:
    Filetype[PDF - 256.13 KB]
  3. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Personal Author:
    Kristiansen, Paul A; Ba, Absatou Ky; Sanou, Idrissa; Ouédraogo, Abdoul-Salam; Ouédraogo, Rasmata; Sangaré, Lassana; Diomandé, Fabien; Kandolo, Denis; Thomas, Jennifer Dolan; Clark, Thomas A; LaForce, Marc; Caugant, Dominique A;
    Published:
    Aug 02 2013
    Source:
    BMC Infect Dis. 2013; 13:363.
    Description:
    Background : The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of the 1-29-year-olds in Burkina Faso in 2010. The aim of this study was to genetically characterize m...
    File Type:
    Filetype[PDF - 300.64 KB]
  4. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
    Personal Author:
    Kristiansen, Paul A; Ba, Absatou Ky; Ouédraogo, Abdoul-Salam; Sanou, Idrissa; Ouédraogo, Rasmata; Sangaré, Lassana; Diomandé, Fabien; Kandolo, Denis; Saga, Inger Marie; Misegades, Lara; Clark, Thomas A; Préziosi, Marie-Pierre; Caugant, Dominique A;
    Published:
    Dec 4 2014
    Source:
    BMC Infect Dis. 14(1).
    Description:
    Background : The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In repeated multicentre cross-sectional studies in Burkina Faso we demonstrated a s...
    File Type:
    Filetype[PDF - 696.37 KB]
  5. Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008
    Personal Author:
    Massenet, Denis; Inrombe, Jermias; Mevoula, Dave-Etienne; Nicolas, Pierre;
    Published:
    Feb 2009
    Source:
    Emerg Infect Dis. 15(2):340-342.
    Description:
    We analyzed results of recent microbiologic surveillance of meningitis in northern Cameroon. During the 2007 and 2008 meningitis seasons, all 57 identified meningococcal isolates were serogroup W135. This situation might indicate that the area is exp...
    File Type:
    Filetype[PDF - 153.63 KB]